Saturday 17 October 2026
Export IQV’s income statement to Excel — free account
IQVIA Holdings Inc.
IQV Healthcare Diagnostics & Research
IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS was flat, free cash flow grew 23.3% and total debt rose 3.29%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.
266.90
4.14
−1.53%
Follow IQV
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
44.99 | 15.78 | 91.47 | 157.66 | 122.72 | 55.87 | 35.09 | 31.09 | 25.92 | 28.43 |
Piotroski F-Score |
5 | 5 | 6 | 5 | 6 | 6 | 7 | 8 | 5 | 4 |
Altman Z-Score |
0.97 | 1.45 | 1.55 | 1.72 | 1.78 | 2.59 | 2.14 | 2.25 | 2.13 | 2.05 |
P/S ratio |
1.68 | 2.24 | 2.27 | 2.72 | 3.02 | 3.89 | 2.65 | 2.83 | 2.31 | 2.38 |
P/FCF ratio |
16.48 | 36.15 | 29.77 | 36.10 | 25.52 | 23.46 | 24.11 | 28.23 | 16.66 | 18.23 |
Altman Z″-Score (non-manufacturers) |
1.07 | 0.98 | 0.90 | 0.80 | 0.87 | 0.89 | 1.06 | 1.16 | 1.32 | 1.14 |
Beneish M-Score |
(1.57) | (2.37) | (2.60) | (2.65) | (2.88) | (2.75) | (2.61) | (2.49) | (2.75) | (2.59) |
P/Operating CF |
25.66 | 93.25 | 56.75 | 51.71 | 45.70 | 78.04 | 68.29 | 56.69 | 40.26 | 52.72 |
P/B ratio |
1.29 | 2.64 | 3.40 | 4.81 | 5.46 | 8.94 | 6.63 | 6.93 | 5.87 | 5.84 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
2.56 | 3.19 | 3.24 | 3.69 | 3.95 | 4.66 | 3.45 | 3.64 | 3.10 | 3.21 |
EV/EBITDA |
18.83 | 17.91 | 17.82 | 20.53 | 22.06 | 24.18 | 16.88 | 17.48 | 14.31 | 15.63 |
EV/Operating CF |
20.27 | 31.90 | 26.90 | 28.86 | 22.92 | 21.97 | 21.98 | 25.37 | 17.59 | 19.72 |
EV/FCF |
25.05 | 51.49 | 42.43 | 48.97 | 33.44 | 28.08 | 31.33 | 36.35 | 22.33 | 24.61 |
Quick Ratio |
1.10 | 1.00 | 0.96 | 0.90 | 0.96 | 0.78 | 0.77 | 0.76 | 0.73 | 0.67 |
Current Ratio |
1.23 | 1.13 | 1.10 | 1.05 | 1.12 | 0.91 | 0.89 | 0.86 | 0.84 | 0.75 |
Net Debt/EBITDA |
6.44 | 5.34 | 5.32 | 5.39 | 5.22 | 3.98 | 3.89 | 3.90 | 3.64 | 4.06 |
Debt/Assets |
33.95% | 44.73% | 48.81% | 50.08% | 51.02% | 49.11% | 50.31% | 51.25% | 51.98% | 52.51% |
Debt/Equity |
0.81 | 1.24 | 1.58 | 1.86 | 2.00 | 2.01 | 2.21 | 2.24 | 2.30 | 2.37 |
Asset Turnover |
0.54 | 0.44 | 0.46 | 0.48 | 0.48 | 0.56 | 0.58 | 0.58 | 0.58 | 0.57 |
Operating CF/Net income |
11.94 | 0.76 | 4.84 | 7.42 | 7.02 | 3.05 | 2.07 | 1.58 | 1.98 | 1.95 |
Capex/Depreciation |
(0.47) | (0.35) | (0.40) | (0.48) | (0.47) | (0.50) | (0.59) | (0.57) | (0.51) | (0.45) |
Interest Coverage |
4.00 | 1.92 | 1.79 | 1.74 | 1.76 | 3.71 | 4.32 | 2.94 | 3.29 | 2.99 |
| 1.69% | 14.93% | 3.41% | 2.89% | 4.45% | 15.68% | 18.48% | 22.87% | 22.55% | 21.42% | |
| 0.57% | 5.80% | 1.14% | 0.83% | 1.17% | 3.92% | 4.36% | 5.22% | 5.13% | 4.79% | |
ROIC |
2.43% | 2.38% | 2.72% | 2.86% | 2.70% | 5.22% | 6.54% | 6.76% | 7.56% | 6.75% |
Return on Tangible Assets |
6.94% | 152.39% | 33.46% | 29.89% | 27.51% | 5,084.21% | (1,678.46%) | (365.05%) | (231.53%) | (87.40%) |
Average Days of Receivables |
93.25 | 80.66 | 86.34 | 86.84 | 79.24 | 68.64 | 74.98 | 83.14 | 76.77 | 76.69 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
14.91% | 16.72% | 16.48% | 15.64% | 15.75% | 14.16% | 14.37% | 13.70% | 12.93% | 12.26% |
Intangible Assets out of Total Assets |
0.81 | 0.81 | 0.79 | 0.76 | 0.73 | 0.74 | 0.74 | 0.73 | 0.71 | 0.72 |
Share Based Compensation of Revenue |
1.17% | 1.09% | 1.09% | 1.32% | 0.84% | 1.23% | 1.35% | 1.45% | 1.34% | 1.51% |
Graham Net Nets |
(0.79) | (0.51) | (0.50) | (0.43) | (0.38) | (0.26) | (0.38) | (0.35) | (0.42) | (0.44) |
Graham Number |
47.82 | 73.38 | 31.23 | 26.61 | 32.84 | 59.89 | 63.38 | 74.46 | 75.55 | 82.96 |
Earnings Yield |
2.22% | 6.34% | 1.09% | 0.63% | 0.81% | 1.79% | 2.85% | 3.22% | 3.86% | 3.52% |
Free Cash Flow Yield |
6.07% | 2.77% | 3.36% | 2.77% | 3.92% | 4.26% | 4.15% | 3.54% | 6.00% | 5.49% |
Revenue per Share |
45.71 | 44.55 | 51.11 | 56.83 | 59.38 | 72.49 | 76.81 | 81.52 | 84.97 | 94.88 |
Operating CF per Share |
5.77 | 4.45 | 6.16 | 7.26 | 10.24 | 15.37 | 12.05 | 11.69 | 14.98 | 15.44 |
Capex per Share |
(1.10) | (1.69) | (2.25) | (2.98) | (3.22) | (3.34) | (3.59) | (3.53) | (3.18) | (3.07) |
Free Cash Flow per Share |
4.67 | 2.76 | 3.90 | 4.28 | 7.02 | 12.03 | 8.45 | 8.16 | 11.80 | 12.37 |
Cash per Share |
8.30 | 4.61 | 4.60 | 4.61 | 9.94 | 7.72 | 6.98 | 8.14 | 10.17 | 12.45 |
Shareholders Equity per Share |
59.42 | 37.85 | 34.14 | 32.10 | 32.83 | 31.57 | 30.73 | 33.25 | 33.46 | 38.57 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
59.42 | 37.85 | 34.14 | 32.10 | 32.83 | 31.57 | 30.73 | 33.25 | 33.46 | 38.57 |
Free Cash Flow |
696.00 | 601.00 | 795.00 | 835.00 | 1,343.00 | 2,302.00 | 1,586.00 | 1,500.00 | 2,139.00 | 2,126.00 |
Working Capital |
632.00 | 398.00 | 340.00 | 181.00 | 532.00 | (478.00) | (597.00) | (895.00) | (1,128.00) | (2,089.00) |
Capital Expenditures |
(164.00) | (369.00) | (459.00) | (582.00) | (616.00) | (640.00) | (674.00) | (649.00) | (577.00) | (528.00) |
Net Current Asset Value |
(9,011.00) | (11,059.00) | (11,721.00) | (12,862.00) | (13,194.00) | (13,884.00) | (14,591.00) | (14,973.00) | (15,003.00) | (17,065.00) |
EV/EBIT |
30.26 | 46.54 | 45.52 | 52.63 | 61.43 | 46.41 | 27.62 | 27.58 | 21.69 | 23.98 |
Capex to Sales |
0.02 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.03 |
Price to Operating Income |
19.91 | 32.67 | 31.94 | 38.80 | 46.89 | 38.77 | 21.26 | 21.42 | 16.18 | 17.76 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.86 | 2.42 | 2.65 | 2.65 | 2.71 | 2.58 | 2.15 | 2.19 | 2.12 | 2.19 |
Cash ROIC |
4.02% | 3.09% | 4.21% | 4.44% | 6.48% | 11.72% | 8.00% | 7.05% | 9.77% | 8.68% |
Accounts Receivable Turnover |
4.63 | 4.99 | 4.52 | 4.35 | 4.45 | 5.47 | 5.18 | 4.70 | 4.63 | 4.89 |
Accounts Payable Turnover |
24.04 | 22.03 | 5.16 | 3.04 | 2.82 | 3.19 | 2.98 | 2.83 | 2.77 | 2.93 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
19.22 | 18.65 | 124.17 | 125.60 | 136.90 | 117.85 | 129.01 | 133.49 | 134.06 | 125.84 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
1,470.50 | 1,942.50 | 2,303.50 | 2,550.50 | 2,552.00 | 2,537.50 | 2,784.50 | 3,186.50 | 3,326.50 | 3,333.50 |
Average Payables |
197.50 | 286.00 | 1,308.50 | 2,403.50 | 2,662.50 | 2,897.00 | 3,148.50 | 3,440.00 | 3,624.00 | 3,717.50 |
Average Assets |
12,567.00 | 22,032.50 | 22,703.00 | 22,900.00 | 23,907.50 | 24,626.50 | 25,013.00 | 26,009.00 | 26,790.00 | 28,421.50 |
Average Common Equity |
4,262.00 | 8,552.00 | 7,599.00 | 6,608.50 | 6,271.50 | 6,161.00 | 5,903.50 | 5,938.50 | 6,089.50 | 6,348.50 |
Columns are period end dates